Hillhouse Capital Management - Q2 2019 holdings

$3.13 Billion is the total value of Hillhouse Capital Management's 35 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 88.9% .

 Value Shares↓ Weighting
IQ BuyIQIYI INCsponsored ads$743,527,000
-9.7%
36,006,170
+4.6%
23.73%
-31.0%
UBER NewUBER TECHNOLOGIES INC$697,346,00015,035,487
+100.0%
22.25%
NIO BuyNIO INCspon ads$106,943,000
-1.6%
41,938,286
+96.7%
3.41%
-24.8%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$100,744,000
+10.3%
594,538
+18.8%
3.22%
-15.6%
TAL BuyTAL EDUCATION GROUPsponsored ads$86,470,000
+288.4%
2,269,549
+267.8%
2.76%
+197.0%
AMZN BuyAMAZON COM INC$81,721,000
+44.4%
43,156
+35.8%
2.61%
+10.5%
BBIO NewBRIDGEBIO PHARMA INC$54,905,0002,035,790
+100.0%
1.75%
PDD BuyPINDUODUO INCsponsored ads$44,756,000
+0.2%
2,169,449
+20.4%
1.43%
-23.4%
TSLA NewTESLA INC$33,005,000147,700
+100.0%
1.05%
NFLX BuyNETFLIX INC$32,655,000
+55.0%
88,902
+50.4%
1.04%
+18.5%
SQ BuySQUARE INCcl a$31,092,000
+206.3%
428,675
+216.4%
0.99%
+134.0%
BILI BuyBILIBILI INCspons ads rep z$29,672,000
+67.6%
1,823,721
+95.2%
0.95%
+28.1%
MOGU NewMOGU INCspon ads$14,887,0005,223,485
+100.0%
0.48%
NXTC NewNEXTCURE INC$14,659,000978,570
+100.0%
0.47%
AKRO NewAKERO THERAPEUTICS INC$5,698,000297,521
+100.0%
0.18%
HOOK NewHOOKIPA PHARMA INC$4,425,000657,540
+100.0%
0.14%
GSAHWS NewGS ACQUISITION HLDGS CORP*w exp 06/12/202$417,000333,333
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONDELEZ INTL INC22Q3 201844.4%
JD COM INC19Q2 201980.2%
SOHU COM INC19Q1 201813.4%
58 COM INC18Q3 20187.8%
TAL EDUCATION GROUP18Q2 20194.4%
CTRIP COM INTL LTD17Q2 201728.4%
BEIGENE LTD14Q2 201925.2%
MELCO RESORT ENTERTAINMENT L14Q3 20186.4%
CAMECO CORP14Q4 20172.2%
ENSTAR GROUP LIMITED12Q2 201921.9%

View Hillhouse Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Hillhouse Capital Management Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
China Jo-Jo Drugstores Holdings, Inc.February 14, 2023403,3344.7%
TScan Therapeutics, Inc.February 14, 2023? ?
Enfusion, Inc.February 14, 20224,975,1837.6%
Enstar Group LTDJuly 19, 2021? ?
Zoom Video Communications, Inc.February 16, 20212,981,2651.5%
NIO Inc.February 14, 2020? ?
Sea LtdFebruary 14, 20204,300,0002.3%
Uxin LtdFebruary 14, 202021,733,0232.6%
Apellis Pharmaceuticals, Inc.February 14, 20192,098,5813.7%
iQIYI, Inc.February 14, 2019240,191,17411.0%

View Hillhouse Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-05
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
42024-02-01
32024-01-25
13F-NT2023-11-14
13F-NT2023-08-14

View Hillhouse Capital Management's complete filings history.

Compare quarters

Export Hillhouse Capital Management's holdings